# Study of Pylopass Versus Placebo in Subjects Who Are Helicobacter Pylori Carriers and With Mild Indigestion

> **NCT02051348** · PHASE2,PHASE3 · COMPLETED · sponsor: **Atlantia Food Clinical Trials** · enrollment: 24 (actual)

## Conditions studied

- HELICOBACTER INFECTION

## Interventions

- **BIOLOGICAL:** Pylopass
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT02051348
- **Lead sponsor:** Atlantia Food Clinical Trials
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2015-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02051348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02051348, "Study of Pylopass Versus Placebo in Subjects Who Are Helicobacter Pylori Carriers and With Mild Indigestion". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT02051348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*